A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons

6.6K views

DOI:

10.3791/57988

January 7th, 2019

In This Article

Summary

The goal of this technique is to prepare a highly enriched culture of primary motoneurons (MNs) from murine spinal cord. To evaluate the consequences of mutations causing MN diseases, we describe here the isolation of these isolated MNs and their transfection by magnetofection.

Abstract

Neurodegeneration of spinal motoneurons (MNs) is implicated in a large spectrum of neurological disorders including amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, and spinal muscular atrophy, which are all associated with muscular atrophy. Primary cultures of spinal MNs have been used widely to demonstrate the involvement of specific genes in such diseases and characterize the cellular consequences of their mutations. This protocol models a primary MN culture derived from the seminal work of Henderson and colleagues more than twenty years ago. First, we detail a method of dissecting the anterior horns of the spinal cord from a mouse embryo and isolating the MNs from neighboring cells using a density gradient. Then, we present a new way of efficiently transfecting MNs with expression plasmids using magnetofection. Finally, we illustrate how to fix and immunostain primary MNs. Using neurofilament mutations that cause Charcot-Marie-Tooth disease type 2, this protocol demonstrates a qualitative approach to expressing proteins of interest and studying their involvement in MN growth, maintenance, and survival.

Introduction

Neuromuscular diseases encompass a variety of clinically and genetically distinct pathologies that are characterized by the alteration of muscle and/or the nervous system. Because of advances in sequencing technologies, hundreds of genes responsible for these rare disorders have been identified during the last decade (list available at the Neuromuscular Disease Center, http://neuromuscular.wustl.edu/index.html). The variety of identified mutations indicates that different mutations in a single gene can cause different phenotypes and diseases1,2,3 and that mutations in differe....

Access restricted. Please log in or start a trial to view this content.

Protocol

All procedures involving animals were accepted by the ethical committee of the institution.

1. Solution Preparation

  1. Prepare 10 mL of 4% BSA dialyzed in L-15 medium.
    1. Dissolve bovine serum albumin powder at 4% (w/v) in 10 mL of L-15 medium.
    2. Add the solution to a 20 mL dialysis cassette with a 20 kDa cut-off. Dialyze against 500 mL of L-15 medium for 3 days under agitation at 4 °C. Change the L-15 medium every day.
    3. Filter the solution through a 0.22 µm membrane and aliquot in 15 mL tubes. Store the tubes at -20 °C.
      NOTE: This protocol uses the following references: unmodified....

Access restricted. Please log in or start a trial to view this content.

Results

After 24 hours in the culture, motoneurons (MNs) should already show significant axonal growth (at least 6 times longer than the soma size). In the following days, axons should continue to grow and display branching (Figure 2). There will be different morphologies due to subtype specificities. For example, median column MNs that innervate axial muscles have shorter and more branched axons than lateral motor column MNs that innervate limb muscles

Access restricted. Please log in or start a trial to view this content.

Discussion

One of the critical points in this protocol is that the mouse embryos are dissected at a precise time window during development (E12.5) to optimize the amount of MNs obtained at the end. In addition, for optimal yield, the dissection should be performed in the morning or early in the afternoon. Before E12.5 (e.g., at E11.5), dissection is difficult, especially regarding the elimination of the meninges. After E12.5, the number of obtained MNs drops significantly. To control the embryo stage of development, adult .......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

We would like to thank the "Association pour le développement de la neurogénétique" for Dr. Jacquier's fellowship and AFM-Telethon for its support through MyoNeurAlp strategic plan. We would also like to thank Dr. Chris Henderson, Dr. William Camu, Dr. Brigitte Pettmann, Dr. Cedric Raoul, and Dr. Georg Haase, who participated in developing and improving the technique and spread their knowledge.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Material
Silicone dissection dishLiving systems instrumentationDD-90-S-BLK-3PKSylgard
round coverslipNeuVitro, Knittel glassGG-12-Pre12 mm
Slide a Lyzer cassettesThermoFisher Scientific6603020,000 MWCO ; 30 mL
Filter unitMilliporeSCGVU02RE
GP Sterile Syringe FiltersMilliporeSLGP033RS
4 well plateThermoFisher Scientific167063Nunclon Delta treated plate
forcepsFST by Dumont11252-20#5 forceps
scissorFST by Dumont14060-10fine scissors
scalpelFST by Dumont10035-20curved blade
scalpelFST by Dumont10316-14micro-knife scalpel
Petri dishGreiner663102ø x h = 100 x 15 mm
15 mL polypropylene tubeFalcon352096
filter paperWatman1001125circle, 125 mm diameter
glass chamber slideLab-Tek1545264 chambers
Plasmid pCAGENAddgene#11160
NameCompanyCatalog NumberComments
Solutions and mediums
Bovine serum albuminSigma-AldrichA9418
L-15 mediumThermoFisher Scientific11415056
L-15 medium, no red phenolThermoFisher Scientific21083027
InsulinSigma-AldrichI6634
PutrescineSigma-AldrichP5780
ConalbuminSigma-AldrichC7786
Sodium seleniteSigma-AldrichS5261
ProgesteroneSigma-AldrichP8783
Poly-DL-OrnithineSigma-AldrichP8638
LamininSigma-AldrichL2020
trypsin 2.5%, 10xThermoFisher Scientific15090046
DNAseSigma-AldrichDN25
PBS w/o Ca MgThermoFisher Scientific14190144without Mg2+ Ca2+
sodium bicarbonateThermoFisher Scientific25080094
Neuron cell culture mediumThermoFisher ScientificA3582901Neurobasal Plus medium
HBSSSigma-AldrichH6648-500ML
HEPES buffer 1 MThermoFisher Scientific15630056
Density gradiant mediumSigma-AldrichD1556Optiprep
supplement mediumThermoFisher ScientificA3582801B-27 Plus
Horse serum heat inactivatedThermoFisher Scientific26050-088
L-Glutamine 200 mMThermoFisher Scientific25030024
2-mercaptoethanolThermoFisher Scientific31350010
penicilline/streptomycineThermoFisher Scientific1514012210,000 U/mL
NameCompanyCatalog NumberComments
Immuno fluorescence
PBS, 10xThermoFisher ScientificX0515without Mg2+ Ca2+
Paraformaldehyde (PFA)Sigma-Aldrich441244
normal goat serumSigma-AldrichG6767
glycineSigma-AldrichG7126
Triton X-100Sigma-AldrichT8787
Choline Acetyl Transferase (CHAT)ChemiconAb144P
Neurofilament H non phosphorylated (SMI32)BiolegendsSMI-32PIF at 1/1000
Islet-1DSHB40.2D6
Islet-2DSHB39.4D5
Hb9DSHB81.5C10
Vectashield mounting mediumVector LabH-1000
Beta3 tubulin (Tuj1 clone)Biolegends801201IF at 1/1000
Lc3bCell Signaling Technology#2775IF at 1/200

References

  1. Gonzalez, M. A., et al. A novel mutation in VCP causes Charcot-Marie-Tooth Type 2 disease. Brain. 137 (11), 2897-2902 (2014).
  2. Johnson, J. O., et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 68 (5), 857-864 (2010).
  3. ....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Motor Neuron CultureSpinal Cord DissectionDensity Gradient CentrifugationMagnetofection TransfectionPrimary Motoneuron EnrichmentNeurofilament ImmunostainingConfocal Microscopy AnalysisCharcot Marie Tooth ModelingAxon Trafficking AssessmentNeurodegeneration Mechanisms